bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
C. auris infections have become increasingly common, and they are more frequently resistant to antifungal drugs doctors use to treat them. Scientists have been attempting to determine the origin of C. auris, but it has been difficult because the pathogen seems to have appeared in several places around the world simultaneously.
By the bioMérieux Connection Editors The University of Antwerp has announced the creation of an Innovative Medicines Initiative (IMI) called VALUE-Dx, in partnership with bioMérieux and Wellcome Trust. According to the University of Antwerp, “The purpose of VALUE-Dx is to transform medical practice to achieve more personalized, evidence-based antibiotic prescription and use in community care …
The cornerstone of Cayuga Medical Center’s investment was the acquisition of a microbial identification technology using mass spectrometry, called MALDI-TOF mass spec. But Cayuga didn’t stop there.
Dr. Ginocchio is the first voting member of PACCARB from the in vitro diagnostics industry.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...